Akinori Arimura

2.6k total citations
67 papers, 2.2k citations indexed

About

Akinori Arimura is a scholar working on Physiology, Pharmacology and Immunology. According to data from OpenAlex, Akinori Arimura has authored 67 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 21 papers in Pharmacology and 15 papers in Immunology. Recurrent topics in Akinori Arimura's work include Asthma and respiratory diseases (20 papers), Inflammatory mediators and NSAID effects (13 papers) and Allergic Rhinitis and Sensitization (9 papers). Akinori Arimura is often cited by papers focused on Asthma and respiratory diseases (20 papers), Inflammatory mediators and NSAID effects (13 papers) and Allergic Rhinitis and Sensitization (9 papers). Akinori Arimura collaborates with scholars based in Japan, United States and United Kingdom. Akinori Arimura's co-authors include Kiyoshi Yasui, Ichiro Hikita, Fujio Asanuma, Masashi Deguchi, Tsutomu Hirasawa, Takeshi Yoshioka, Morio Nagira, Shuuichi Matsushima, Toshikatsu Shimizu and Mikinori Torii and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Akinori Arimura

65 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akinori Arimura Japan 24 468 456 433 431 332 67 2.2k
Shiro Nakaike Japan 23 306 0.7× 414 0.9× 63 0.1× 531 1.2× 238 0.7× 77 1.6k
Toshimitsu Yamada Japan 20 449 1.0× 523 1.1× 146 0.3× 31 0.1× 154 0.5× 52 1.6k
S. Charleson Canada 25 791 1.7× 770 1.7× 294 0.7× 80 0.2× 227 0.7× 51 2.7k
Edward F. Webb United States 20 402 0.9× 778 1.7× 233 0.5× 79 0.2× 113 0.3× 36 1.7k
Armin Hatzelmann Germany 36 1.3k 2.8× 2.1k 4.7× 785 1.8× 46 0.1× 122 0.4× 58 3.6k
Valérie Capra Italy 29 805 1.7× 1.0k 2.3× 242 0.6× 35 0.1× 157 0.5× 59 2.5k
John R. Brashler United States 22 1.8k 3.7× 933 2.0× 188 0.4× 77 0.2× 334 1.0× 59 2.8k
Tetsuro Yoshimaru Japan 23 292 0.6× 702 1.5× 74 0.2× 53 0.1× 215 0.6× 50 1.5k
John M. Yanni United States 23 199 0.4× 246 0.5× 32 0.1× 136 0.3× 501 1.5× 52 1.6k
R Cirillo Italy 23 245 0.5× 1.1k 2.3× 104 0.2× 49 0.1× 99 0.3× 69 2.5k

Countries citing papers authored by Akinori Arimura

Since Specialization
Citations

This map shows the geographic impact of Akinori Arimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akinori Arimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akinori Arimura more than expected).

Fields of papers citing papers by Akinori Arimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akinori Arimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akinori Arimura. The network helps show where Akinori Arimura may publish in the future.

Co-authorship network of co-authors of Akinori Arimura

This figure shows the co-authorship network connecting the top 25 collaborators of Akinori Arimura. A scholar is included among the top collaborators of Akinori Arimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akinori Arimura. Akinori Arimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jain, Nitin, Catherine C. Coombs, James D’Olimpio, et al.. (2024). Preliminary Results from a Phase 1b Study of Non-Covalent Pan-Mutant BTK Inhibitor Docirbrutinib (AS-1763) in Patients with Previously Treated B-Cell Malignancies. Blood. 144(Supplement 1). 1866–1866.
3.
4.
Arkenau, Hendrik‐Tobias, Antoîne Italiano, Gabriel Mak, et al.. (2018). An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours. European Journal of Cancer. 103. 17–23. 10 indexed citations
5.
Obara, Wataru, Masatoshi Eto, Hiromitsu Mimata, et al.. (2016). A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder. Annals of Oncology. 28(4). 798–803. 44 indexed citations
6.
Takahashi, Go, Fujio Asanuma, Noriko Suzuki, et al.. (2015). Effect of the potent and selective DP1 receptor antagonist, asapiprant (S-555739), in animal models of allergic rhinitis and allergic asthma. European Journal of Pharmacology. 765. 15–23. 17 indexed citations
7.
Inagaki, Masanao, Hiroshi Hashizume, Yasuhiko Fujii, et al.. (2012). Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agent. Bioorganic & Medicinal Chemistry Letters. 22(8). 2898–2901. 9 indexed citations
8.
Yoshioka, Takeshi, Kinichi Imura, Makoto Asakawa, et al.. (2008). Impact of the Gly573Ser Substitution in TRPV3 on the Development of Allergic and Pruritic Dermatitis in Mice. Journal of Investigative Dermatology. 129(3). 714–722. 142 indexed citations
9.
Yoshida, Hiroshi, Hiroyuki Yamada, Kenji Abe, et al.. (2008). The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis. Haematologica. 93(10). 1495–1504. 23 indexed citations
10.
Yamamoto, Mina, Kinichi Imura, Ichiro Hikita, et al.. (2008). Inhibitory Effect of a Potent and Selective Cytosolic Phospholipase A<sub>2</sub>α Inhibitor RSC-3388 on Skin Inflammation in Mice. Pharmacology. 81(4). 301–311. 17 indexed citations
11.
Oku, Hisashi, Toshikatsu Shimizu, Tomoji Kawabata, et al.. (2008). Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. European Journal of Pharmacology. 590(1-3). 400–408. 347 indexed citations
12.
13.
Asakawa, Makoto, Takeshi Yoshioka, Takaji Matsutani, et al.. (2006). Association of a Mutation in TRPV3 with Defective Hair Growth in Rodents. Journal of Investigative Dermatology. 126(12). 2664–2672. 150 indexed citations
14.
Asakawa, Makoto, Takeshi Yoshioka, Ichiro Hikita, et al.. (2005). WBN/Kob-Ht Rats Spontaneously Develop Dermatitis under Conventional Conditions: Another Possible Model for Atopic Dermatitis. EXPERIMENTAL ANIMALS. 54(5). 461–465. 14 indexed citations
15.
Yagami, Tatsurou, Keiichi Ueda, Kenji Asakura, et al.. (2003). Novel binding sites of 15-deoxy-Δ12,14-prostaglandin J2 in plasma membranes from primary rat cortical neurons. Experimental Cell Research. 291(1). 212–227. 32 indexed citations
16.
Schröder, Andreas, et al.. (2002). Cutting Edge: STAT6 Serves as a Positive and Negative Regulator of Gene Expression in IL-4-Stimulated B Lymphocytes. The Journal of Immunology. 168(3). 996–1000. 78 indexed citations
17.
Kawada, Kenji, Akinori Arimura, Tatsuo Tsuri, et al.. (1998). Total Synthesis of Terprenin, a Highly Potent and Novel Immunoglobulin E Antibody Suppressant. Angewandte Chemie International Edition. 37(7). 973–975. 37 indexed citations
18.
Kanemasa, Toshiyuki, et al.. (1992). Contraction of guinea pig lung parenchyma by pancreatic type phospholipase A2 via its specific binding site. FEBS Letters. 303(2-3). 217–220. 47 indexed citations
19.
Miura, Toru, et al.. (1990). A Method for Evaluating Anti-Allergic Drugs by Simultaneously Induced Passive Cutaneous Anaphylaxis and Mediator Cutaneous Reactions. International Archives of Allergy and Immunology. 92(3). 209–216. 29 indexed citations
20.
Arimura, Akinori, et al.. (1990). Active and Passive Cutaneous Anaphylaxis in Wbb6f1Mouse, A Mast Cell-Deficient Strain. Immunological Investigations. 19(3). 227–233. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiro Nakaike Breakdown of academic impact, for papers by Toshimitsu Yamada Breakdown of academic impact, for papers by S. Charleson Breakdown of academic impact, for papers by Edward F. Webb Breakdown of academic impact, for papers by Armin Hatzelmann Breakdown of academic impact, for papers by Valérie Capra Breakdown of academic impact, for papers by John R. Brashler Breakdown of academic impact, for papers by Tetsuro Yoshimaru Breakdown of academic impact, for papers by John M. Yanni Breakdown of academic impact, for papers by R Cirillo
Rankless by CCL
2026